Alterations in the cytoarchitecture of the organ of Corti (OC) cause hearing loss in humans. The regulation of the actin cytoskeleton in epithelial cells of the OC is one of the key elements to understanding the pathogenesis of deafness. But little is known about the mechanism of actin-cytoskeletal modeling especially in supporting cells rather than sensory cells. The unconventional myosin-X (myoX) is an actin-associated motor protein that localizes to supporting cells. The overall hypothesis is that myoX and its binding partners are important regulators of the cytoarchitecture in the OC.
The Specific Aims are to: (1) Investigate the developmental expression profiles of myoX in the OC of developing rodents;(2) Investigate the role of the binding proteins in the regulation of dimerization of myoX;and (3) Investigate the role of myoX in regulation of actin dynamics in cultured OC. These goals, to be accomplished by a combination of biochemical and cell biological approaches, will provide new insights into the development of new therapies and prevention of hearing loss.

Public Health Relevance

Impaired cell structures that are formed by actin in the sensory epithelium cause hearing loss in humans. Our long-term goal is to develop methods for the treatment of deafness based on understanding how regulation of actin by myosin-X and its binding partners results in forming normal inner ear structures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Small Research Grants (R03)
Project #
1R03DC009887-01A2
Application #
8181833
Study Section
Special Emphasis Panel (ZDC1-SRB-Y (51))
Program Officer
Freeman, Nancy
Project Start
2011-08-25
Project End
2014-07-31
Budget Start
2011-08-25
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$203,000
Indirect Cost
Name
Boston Biomedical Research Institute
Department
Type
DUNS #
058893371
City
Watertown
State
MA
Country
United States
Zip Code
02472